BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 20522957)

  • 1. Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells.
    Jeong A; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Bae H; Kim SH
    Biol Pharm Bull; 2010; 33(6):945-50. PubMed ID: 20522957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol inhibits vascular endothelial growth factor-A--induced migration of human umbilical vein endothelial cells.
    Matsunaga N; Shimazawa M; Otsubo K; Hara H
    J Pharmacol Sci; 2008 Jan; 106(1):128-35. PubMed ID: 18187933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite.
    Yue GG; Lee JK; Kwok HF; Cheng L; Wong EC; Jiang L; Yu H; Leung HW; Wong YL; Leung PC; Fung KP; Lau CB
    Sci Rep; 2015 Jun; 5():11149. PubMed ID: 26053458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigment epithelium-derived factor inhibits fibroblast-growth-factor-2-induced capillary morphogenesis of endothelial cells through Fyn.
    Kanda S; Mochizuki Y; Nakamura T; Miyata Y; Matsuyama T; Kanetake H
    J Cell Sci; 2005 Mar; 118(Pt 5):961-70. PubMed ID: 15713745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
    Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
    Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.
    Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX
    Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGF-R2.
    Xiao D; Li M; Herman-Antosiewicz A; Antosiewicz J; Xiao H; Lew KL; Zeng Y; Marynowski SW; Singh SV
    Nutr Cancer; 2006; 55(1):94-107. PubMed ID: 16965246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
    Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
    Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
    Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
    Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cultivated Orostachys japonicus extract inhibits VEGF-induced angiogenesis via regulation of VEGFR2 signaling pathway in vitro and in vivo.
    Cho HD; Lee KW; Won YS; Kim JH; Seo KI
    J Ethnopharmacol; 2020 Jun; 256():112664. PubMed ID: 32045685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.
    Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI
    Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases.
    Kim SA; Lee HJ; Ahn KS; Lee HJ; Lee EO; Ahn KS; Choi SH; Jung SJ; Kim JY; Baek N; Kim SH
    Biol Pharm Bull; 2009 Jul; 32(7):1142-7. PubMed ID: 19571375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
    Cao ZX; Zheng RL; Lin HJ; Luo SD; Zhou Y; Xu YZ; Zeng XX; Wang Z; Zhou LN; Mao YQ; Yang L; Wei YQ; Yu LT; Yang SY; Zhao YL
    Cell Physiol Biochem; 2011; 27(5):565-74. PubMed ID: 21691074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways.
    Huh JE; Lee EO; Kim MS; Kang KS; Kim CH; Cha BC; Surh YJ; Kim SH
    Carcinogenesis; 2005 Aug; 26(8):1436-45. PubMed ID: 15845650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
    Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short peptide derived from pigment epithelial-derived factor exhibits an angioinhibitory effect.
    Ho TC; Yeh SI; Chen SL; Chu TW; Tsao YP
    BMC Ophthalmol; 2022 Feb; 22(1):88. PubMed ID: 35193548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.
    Chao TH; Tseng SY; Li YH; Liu PY; Cho CL; Shi GY; Wu HL; Chen JH
    Clin Sci (Lond); 2012 Aug; 123(3):147-59. PubMed ID: 22339730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
    Fan Y; Peng A; He S; Shao X; Nie C; Chen L
    J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
    Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H
    Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells.
    Mu H; Ohashi R; Yan S; Chai H; Yang H; Lin P; Yao Q; Chen C
    Cardiovasc Res; 2006 Apr; 70(1):146-57. PubMed ID: 16515776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.